These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30834836)

  • 1. Synthesis, Screening and Docking Analysis of Hispolon Pyrazoles and Isoxazoles as Potential Antitubercular Agents.
    Balaji NV; HariBabu B; Rao VU; Subbaraju GV; Nagasree KP; Kumar MMK
    Curr Top Med Chem; 2019; 19(9):662-682. PubMed ID: 30834836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
    Balaji NV; Hari Babu B; Subbaraju GV; Purna Nagasree K; Murali Krishna Kumar M
    Bioorg Med Chem Lett; 2017 Jan; 27(1):11-15. PubMed ID: 27894872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
    Nayak N; Ramprasad J; Dalimba U
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and biological screening of pyrazole-conjugated benzothiazole analogs.
    Bhat M; Belagali SL
    Future Med Chem; 2018 Jan; 10(1):71-87. PubMed ID: 29235357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
    Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
    Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
    Kumar G; Siva Krishna V; Sriram D; Jachak SM
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents.
    Meta E; Brullo C; Tonelli M; Franzblau SG; Wang Y; Ma R; Baojie W; Orena BS; Pasca MR; Bruno O
    Med Chem; 2019; 15(1):17-27. PubMed ID: 29792151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
    Modi P; Patel S; Chhabria M
    Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
    Velaparthi S; Brunsteiner M; Uddin R; Wan B; Franzblau SG; Petukhov PA
    J Med Chem; 2008 Apr; 51(7):1999-2002. PubMed ID: 18335974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Aminopyrazole Tagged Hydrazones as Anti-Tubercular Agents: Synthesis and Molecular Docking Studies.
    Padmini T; Bhikshapathi D; Suresh K; Kulkarni R; Kamal BR
    Med Chem; 2021; 17(4):344-351. PubMed ID: 32407282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
    Pathak RB; Chovatia PT; Parekh HH
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
    Bhatt JD; Chudasama CJ; Patel KD
    Bioorg Med Chem; 2015 Dec; 23(24):7711-6. PubMed ID: 26631439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
    Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
    Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
    Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
    Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.
    Alegaon SG; Alagawadi KR; Dadwe DH
    Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MoS
    Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
    ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives.
    Naidu KM; Srinivasarao S; Agnieszka N; Ewa AK; Kumar MM; Chandra Sekhar KV
    Bioorg Med Chem Lett; 2016 May; 26(9):2245-50. PubMed ID: 27020525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.